{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:13:53Z","timestamp":1780496033350,"version":"3.54.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National R&D Plan"},{"DOI":"10.13039\/501100004587","name":"ISCIII","doi-asserted-by":"crossref","award":["PI13\/01471"],"award-info":[{"award-number":["PI13\/01471"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.ijantimicag.2017.01.039","type":"journal-article","created":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T01:49:30Z","timestamp":1496281770000},"page":"191-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["In-vitro activity of several antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA) isolates expressing aminoglycoside-modifying enzymes: potency of plazomicin alone and in combination with other agents"],"prefix":"10.1016","volume":"50","author":[{"given":"Mar\u00eda Carmen","family":"L\u00f3pez D\u00edaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"R\u00edos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iciar","family":"Rodr\u00edguez-Avial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Janneth","family":"Simaluiza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jos\u00e9","family":"Picazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Culebras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2017.01.039_bib0010","doi-asserted-by":"crossref","first-page":"19688","DOI":"10.2807\/ese.15.41.19688-en","article-title":"Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe","volume":"15","author":"K\u00f6ck","year":"2010","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ijantimicag.2017.01.039_bib0015","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1128\/CMR.00042-09","article-title":"Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications","volume":"23","author":"Howden","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2017.01.039_bib0020","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1128\/MMBR.57.1.138-163.1993","article-title":"Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes","volume":"57","author":"Shaw","year":"1993","journal-title":"Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2017.01.039_bib0025","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1128\/AAC.00274-15","article-title":"In vitro activity of dalbavancin against drug-resistant Staphylococcus aureus isolates from a global surveillance program","volume":"59","author":"McCurdy","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.01.039_bib0030","first-page":"252","article-title":"In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus","volume":"19","author":"Sahuquillo Arce","year":"2006","journal-title":"Rev Esp Quimioter"},{"key":"10.1016\/j.ijantimicag.2017.01.039_bib0035","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1128\/AAC.00682-15","article-title":"Synergistic effect of membrane-active peptides polymyxin B and gramicidin S on multidrug-resistant strains and biofilms of Pseudomonas aeruginosa","volume":"59","author":"Berditsch","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.01.039_bib0040","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1128\/AAC.01365-09","article-title":"Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis","volume":"54","author":"Micek","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.01.039_bib0045","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.drup.2010.08.003","article-title":"Aminoglycoside modifying enzymes","volume":"13","author":"Ramirez","year":"2010","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.ijantimicag.2017.01.039_bib0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.15171\/bi.2015.15","article-title":"Detecting the frequency of aminoglycoside modifying enzyme encoding genes among clinical isolates of methicillin-resistant Staphylococcus aureus","volume":"5","author":"Shokravi","year":"2015","journal-title":"Bioimpacts"},{"key":"10.1016\/j.ijantimicag.2017.01.039_bib0055","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1586\/eri.12.25","article-title":"Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin","volume":"10","author":"Zhanel","year":"2012","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2017.01.039_bib0060","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ijantimicag.2011.05.016","article-title":"Activity of ACHN-490 against meticillin-resistant Staphylococcus aureus (MRSA) isolates from patients in US hospitals","volume":"38","author":"Tenover","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2017.01.039_bib0065","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1128\/AAC.00873-15","article-title":"Can plazomicin alone or in combination be a therapeutic option against carbapenem-resistant Acinetobacter baumannii?","volume":"59","author":"Garc\u00eda-Salguero","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.01.039_bib0070","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1128\/AAC.01350-09","article-title":"Antistaphylococcal activity of ACHN-490 tested alone and in combination with other agents by time-kill assay","volume":"54","author":"Lin","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.01.039_bib0075","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ijantimicag.2015.07.021","article-title":"In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains","volume":"46","author":"Rodr\u00edguez-Avial","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2017.01.039_bib0080","series-title":"Performance standards for antimicrobial susceptibility testing; Twenty-Fourth informational supplement M100-S24","author":"Clinical Laboratory Standards Institute","year":"2014"},{"key":"10.1016\/j.ijantimicag.2017.01.039_bib0085","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000313523","article-title":"Oxacillin resistance of Staphylococcus aureus isolated from the university hospital of Botucatu Medical School in Brazil","volume":"56","author":"Martins","year":"2010","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijantimicag.2017.01.039_bib0090","series-title":"Breakpoint tables for interpretation of MICs and zone diameters","author":"European Committee on Antimicrobial Susceptibility Testing","year":"2015"},{"key":"10.1016\/j.ijantimicag.2017.01.039_bib0095","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/jac\/48.suppl_1.87","article-title":"Interpretative reading: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes","volume":"48","author":"Livermore","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.01.039_bib0100","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.eimc.2010.02.003","article-title":"Lectura interpretada del antibiograma de cocos gram positivos","volume":"28","author":"Torres","year":"2010","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.ijantimicag.2017.01.039_bib0105","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3346\/jkms.2003.18.5.631","article-title":"Multiplex PCR for the detection of genes encoding aminoglycoside modifying enzymes and methicillin resistance among Staphylococcus species","volume":"18","author":"Choi","year":"2003","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.ijantimicag.2017.01.039_bib0110","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1128\/AAC.43.1.157","article-title":"Detection of a streptomycin\/spectinomycin adenylyltransferase gene (aadA) in Enterococcus faecalis","volume":"43","author":"Clark","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.01.039_bib0115","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/jac\/dki477","article-title":"In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis","volume":"57","author":"Petersen","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.01.039_bib0120","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1128\/AAC.02763-14","article-title":"Cefoxitin continuous infusion for lung infection caused by the Mycobacterium abscessus group","volume":"58","author":"Czaja","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.01.039_bib0125","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1128\/AAC.00741-13","article-title":"Evaluation of double- and triple-antibiotic combinations for VIM and NDM-producing Klebsiella pneumoniae by in vitro time-kill experiments","volume":"58","author":"T\u00e4ngd\u00e9n","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.01.039_bib0130","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.eimc.2008.09.003","article-title":"Consensus document for the treatment of bacteremia and endocarditis caused by methicillin-resistent Staphylococcus aureus","volume":"27","author":"Gudiol","year":"2009","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.ijantimicag.2017.01.039_bib0135","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1128\/AAC.02744-13","article-title":"In vitro activity of plazomicin against 5.015 Gram-negative and Gram-positive clinical isolates obtained from patients in Canadian hospitals as part of the CANWARD study, 2011\u20132012","volume":"58","author":"Walkty","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.01.039_bib0140","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.micres.2005.05.002","article-title":"Investigation of aminoglycoside modifying enzyme genes in methicillin-resistant staphylococci","volume":"161","author":"Ardic","year":"2006","journal-title":"Microbiol Res"},{"key":"10.1016\/j.ijantimicag.2017.01.039_bib0145","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/jac\/dkh453","article-title":"Phenotypic and genotypic aminoglycoside resistance in blood culture isolates of coagulase-negative Staphylococci from a single neonatal intensive care unit, 1989\u20132000","volume":"54","author":"Klingenberg","year":"2004","journal-title":"J Antimicrob Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917301723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917301723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T04:21:00Z","timestamp":1602217260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857917301723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0924857917301723"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.01.039","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In-vitro activity of several antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA) isolates expressing aminoglycoside-modifying enzymes: potency of plazomicin alone and in combination with other agents","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.01.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}